APAC Ablation Devices Market Size

APAC Ablation Technologies Market Analysis

The Asia-Pacific Ablation Devices Market is expected to register a CAGR of nearly 7.6% during the forecast period.

The COVID-19 pandemic had a significant impact on the market initially. Due to the lockdown conditions imposed in various Asian countries, surgical procedures reduced considerably including ablation procedures. For instance, according to an article published by the Journal of Clinical Medicine in October 2022, a study was conducted in China which showed that the COVID-19 pandemic had a significant impact on the clinical practice patterns of atrial fibrillation and the catheter ablation and percutaneous left atrial appendage occlusion procedures were significantly reduced. Hence, the COVID-19 pandemic had a significant impact on the market initially. However, as the pandemic has currently subsided, the ablation procedures are expected to take place normally, leading to stable growth of the studied market.

Rising incidences of diseases such as cancer and cardiac ailments are expected to boost the demand for ablation procedures. The technological advancements to design high-end products and growing demand for treatment procedures, which are minimally invasive are also expected to boost the ablation technologies market. Furthermore, the ageing population having a higher risk of target diseases is another vital factor driving the demand for ablation devices.

Japan has a fast ageing population. For instance, according to the data from the 2022 White Paper on Ageing Society, published by the Cabinet Office of Japan, it is estimated that Japan's population aged 65 and over stands at just over 36.21 million in 2021, accounting for 28.9% of the total population. As the geriatric population is expected to increase in coming years who are more prone to chronic diseases such as cancer, cardiovascular diseases, and urinary disorders which are expected to increase the ablation procedures in near future which shows a positive impact on the market.

Furthermore, government initiatives to treat various diseases are also expected to enhance the adoption of ablation devices. For instance, in May 2022, MoHFW of India proposed to increase the number of cataract surgeries to be carried progressively across the country in the financial year 2022-23 to 7.5 million, 9 million in 2023-24, and 10.5 million in 2024-25: amounting to a total of 27 million of surgeries in the next three years.

Moreover, product launches by various market players are also expected to increase market growth. For instance, in November 2021, Medtronic India launched the Arctic Front Cardiac Cryoablation Catheter for the treatment of atrial fibrillation in India.

Therefore, rising prevalence of cancer and other chronic diseases, increasing product launches, and rising geriatric population is expected to enhance the growth of the market over the forecast period. However, high cost of devices, lack of awareness, and stringent regulations are some of the market challenges which is expected to hinder the market growth.